HIF mediated and DNA damage independent histone H2AX phosphorylation in chronic hypoxia
暂无分享,去创建一个
[1] W. Mckenna,et al. Targeting radiation-resistant hypoxic tumour cells through ATR inhibition , 2012, British Journal of Cancer.
[2] G. Kristiansen,et al. Non-canonical HIF-2α function drives autonomous breast cancer cell growth via an AREG–EGFR/ErbB4 autocrine loop , 2012, Oncogene.
[3] D. Biard,et al. A DNA-dependent stress response involving DNA-PK occurs in hypoxic cells and contributes to cellular adaptation to hypoxia , 2011, Journal of Cell Science.
[4] M. Dewhirst,et al. Molecular Imaging of Hypoxia , 2011, The Journal of Nuclear Medicine.
[5] James B. Mitchell,et al. Low-field magnetic resonance imaging to visualize chronic and cycling hypoxia in tumor-bearing mice. , 2010, Cancer research.
[6] Lionel Flamant,et al. Anti-apoptotic role of HIF-1 and AP-1 in paclitaxel exposed breast cancer cells under hypoxia , 2010, Molecular Cancer.
[7] S. Lowe,et al. HIF-1 antagonizes p53-mediated apoptosis through a secreted neuronal tyrosinase , 2010, Nature.
[8] Xiao-dan Liu,et al. DNA-PKcs plays a dominant role in the regulation of H2AX phosphorylation in response to DNA damage and cell cycle progression , 2010, BMC Molecular Biology.
[9] A. Nussenzweig,et al. Histone H2AX is integral to hypoxia-driven neovascularization , 2009, Nature Medicine.
[10] K. Khanna,et al. Involvement of Exo1b in DNA damage-induced apoptosis , 2009, Nucleic acids research.
[11] P. Beard,et al. H2AX Is Required for Cell Cycle Arrest via the p53/p21 Pathway , 2009, Molecular and Cellular Biology.
[12] D. Guidolin,et al. Transcriptional regulation of hypoxia-inducible factor 1alpha by HIPK2 suggests a novel mechanism to restrain tumor growth. , 2009, Biochimica et biophysica acta.
[13] R. Wenger,et al. Impaired DNA double-strand break repair contributes to chemoresistance in HIF-1 alpha-deficient mouse embryonic fibroblasts. , 2008, Carcinogenesis.
[14] M. Koike,et al. Tissue-specific DNA-PK-dependent H2AX phosphorylation and gamma-H2AX elimination after X-irradiation in vivo. , 2008, Biochemical and biophysical research communications.
[15] A. Giaccia,et al. Hypoxic Conditions Atm Activation and Signaling Under , 2008 .
[16] Xin Wang,et al. Effects of lentivirus-mediated HIF-1α knockdown on hypoxia-related cisplatin resistance and their dependence on p53 status in fibrosarcoma cells , 2008, Cancer Gene Therapy.
[17] F. de Longueville,et al. Hypoxia induces protection against etoposide-induced apoptosis: molecular profiling of changes in gene expression and transcription factor activity , 2008, Molecular Cancer.
[18] Richard P. Hill,et al. Hypoxia and metabolism: Hypoxia, DNA repair and genetic instability , 2008, Nature Reviews Cancer.
[19] Tae Funakoshi,et al. 2-methoxyestradiol inhibits hypoxia-inducible factor-1{alpha} and suppresses growth of lesions in a mouse model of endometriosis. , 2008, The American journal of pathology.
[20] F. Bunz,et al. ATM and ATR: Components of an Integrated Circuit , 2007, Cell cycle.
[21] T. Osaki,et al. The involvement of hypoxia‐inducible factor‐1α in the susceptibility to γ‐rays and chemotherapeutic drugs of oral squamous cell carcinoma cells , 2007 .
[22] V. Grégoire,et al. Preconditioning of the tumor vasculature and tumor cells by intermittent hypoxia: implications for anticancer therapies. , 2006, Cancer research.
[23] Q. Peng,et al. Induction of hypoxia-inducible factor-1α overexpression by cobalt chloride enhances cellular resistance to photodynamic therapy , 2006 .
[24] G. Semenza,et al. Heterozygous HIF‐1α deficiency impairs carotid body‐mediated systemic responses and reactive oxygen species generation in mice exposed to intermittent hypoxia , 2006, The Journal of physiology.
[25] Roland H Wenger,et al. Increased Prolyl 4-Hydroxylase Domain Proteins Compensate for Decreased Oxygen Levels , 2006, Journal of Biological Chemistry.
[26] S. Fesik,et al. Hypoxia-Inducible Factor-1 Inhibition in Combination with Temozolomide Treatment Exhibits Robust Antitumor Efficacy In vivo , 2006, Clinical Cancer Research.
[27] Manuela Milani,et al. Hypoxia-Inducible Factor-1α Expression Predicts a Poor Response to Primary Chemoendocrine Therapy and Disease-Free Survival in Primary Human Breast Cancer , 2006, Clinical Cancer Research.
[28] V. Natale,et al. H2AX phosphorylation within the G1 phase after UV irradiation depends on nucleotide excision repair and not DNA double-strand breaks. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[29] R. Nagatomi,et al. Knockdown of hypoxia‐inducible factor‐1α by siRNA inhibits C2C12 myoblast differentiation , 2006, Journal of cellular biochemistry.
[30] J. Pouysségur,et al. Hypoxia signalling in cancer and approaches to enforce tumour regression , 2006, Nature.
[31] David J. Chen,et al. DNA-PK phosphorylates histone H2AX during apoptotic DNA fragmentation in mammalian cells. , 2006, DNA repair.
[32] R. Zhao,et al. Knockdown of hypoxia-inducible factor-1alpha in breast carcinoma MCF-7 cells results in reduced tumor growth and increased sensitivity to methotrexate. , 2006, Biochemical and biophysical research communications.
[33] Xianrang Song,et al. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1α gene , 2006, Cancer Chemotherapy and Pharmacology.
[34] J. Erler,et al. Reversing Hypoxic Cell Chemoresistance in Vitro Using Genetic and Small Molecule Approaches Targeting Hypoxia Inducible Factor-1 , 2006, Molecular Pharmacology.
[35] Y. Doki,et al. Overexpression of hypoxia-inducible factor-1 alpha in gastric adenocarcinoma , 2006, Gastric Cancer.
[36] T. Hunter,et al. Turning the Replication Checkpoint On and Off , 2006, Cell cycle.
[37] G. Camenisch,et al. Integration of Oxygen Signaling at the Consensus HRE , 2005, Science's STKE.
[38] P. Olive,et al. DNA-PK is responsible for enhanced phosphorylation of histone H2AX under hypertonic conditions. , 2005, DNA repair.
[39] M. Dewhirst,et al. Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity. , 2005, Cancer cell.
[40] M. Dewhirst,et al. Spatial heterogeneity and oxygen dependence of glucose consumption in R3230Ac and fibrosarcomas of the Fischer 344 rat. , 2005, Cancer research.
[41] F. Kaper,et al. Anoxia is necessary for tumor cell toxicity caused by a low-oxygen environment. , 2005, Cancer research.
[42] A. Harris,et al. Enhanced response to radiotherapy in tumours deficient in the function of hypoxia-inducible factor-1. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[43] C. Bishop,et al. Identification and characterization of a novel testicular germ cell‐specific gene Ggnbp1 , 2005, Molecular reproduction and development.
[44] C. Van Waes,et al. 2-Methoxyestradiol Inhibits Hypoxia-Inducible Factor 1α, Tumor Growth, and Angiogenesis and Augments Paclitaxel Efficacy in Head and Neck Squamous Cell Carcinoma , 2004, Clinical Cancer Research.
[45] C. Supuran,et al. Hypoxia activates the capacity of tumor‐associated carbonic anhydrase IX to acidify extracellular pH , 2004, FEBS letters.
[46] M. Dewhirst,et al. Enhancement of Hypoxia-Induced Tumor Cell Death In vitro and Radiation Therapy In vivo by Use of Small Interfering RNA Targeted to Hypoxia-Inducible Factor-1α , 2004, Cancer Research.
[47] E. Wall,et al. The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis , 2004, Journal of Clinical Pathology.
[48] Michel Nussenzweig,et al. H2AX: the histone guardian of the genome. , 2004, DNA repair.
[49] D. W. Kim,et al. Association of DNA-dependent protein kinase with hypoxia inducible factor-1 and its implication in resistance to anticancer drugs in hypoxic tumor cells , 2004, Experimental & Molecular Medicine.
[50] J. Brown,et al. Exploiting tumour hypoxia in cancer treatment , 2004, Nature Reviews Cancer.
[51] Christopher J. Schofield,et al. Oxygen sensing by HIF hydroxylases , 2004, Nature Reviews Molecular Cell Biology.
[52] Crispin J. Miller,et al. Hypoxia-Mediated Down-Regulation of Bid and Bax in Tumors Occurs via Hypoxia-Inducible Factor 1-Dependent and -Independent Mechanisms and Contributes to Drug Resistance , 2004, Molecular and Cellular Biology.
[53] P. Jeggo,et al. ATM and DNA-PK Function Redundantly to Phosphorylate H2AX after Exposure to Ionizing Radiation , 2004, Cancer Research.
[54] A. Giaccia,et al. Comparison of hypoxia-induced replication arrest with hydroxyurea and aphidicolin-induced arrest. , 2003, Mutation research.
[55] T. Ried,et al. H2AX Haploinsufficiency Modifies Genomic Stability and Tumor Susceptibility , 2003, Cell.
[56] R. Agarwal,et al. Ovarian cancer: strategies for overcoming resistance to chemotherapy , 2003, Nature Reviews Cancer.
[57] A. Giaccia,et al. Hypoxia-Induced Gene Expression Occurs Solely through the Action of Hypoxia-Inducible Factor 1α (HIF-1α): Role of Cytoplasmic Trapping of HIF-2α , 2003, Molecular and Cellular Biology.
[58] R. Wenger,et al. The hypoxia-inducible factor-1α is a negative factor for tumor therapy , 2003, Oncogene.
[59] A. Giaccia,et al. ATR/ATM Targets Are Phosphorylated by ATR in Response to Hypoxia and ATM in Response to Reoxygenation* , 2003, The Journal of Biological Chemistry.
[60] M. Gassmann,et al. Regulation of the multidrug resistance transporter P‐glycoprotein in multicellular tumor spheroids by hypoxia‐inducible factor‐1 and reactive oxygen species , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[61] L. Einhorn. Chemotherapeutic and surgical strategies for germ cell tumors. , 2002, Chest surgery clinics of North America.
[62] A. Harris,et al. Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer. , 2002, International journal of radiation oncology, biology, physics.
[63] R. Wenger,et al. Cellular adaptation to hypoxia: O2‐sensing protein hydroxylases, hypoxia‐inducible transcription factors, and O2‐regulated gene expression , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[64] Michael C. Montalto,et al. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. , 2002, Cancer research.
[65] M. Gassmann,et al. Rescue of hypoxia-inducible factor-1alpha-deficient tumor growth by wild-type cells is independent of vascular endothelial growth factor. , 2002, Cancer research.
[66] Michel C. Nussenzweig,et al. Genomic Instability in Mice Lacking Histone H2AX , 2002, Science.
[67] A. Giaccia,et al. Hypoxia Links ATR and p53 through Replication Arrest , 2002, Molecular and Cellular Biology.
[68] N. Sang,et al. Hypoxia-inducible Factor-1-mediated Expression of the 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) Gene , 2002, The Journal of Biological Chemistry.
[69] P. Thibault,et al. Transcription Factor HIF-1 Is a Necessary Mediator of the Pasteur Effect in Mammalian Cells , 2001, Molecular and Cellular Biology.
[70] D. Faller,et al. Hypoxia-activated ligand HAL-1/13 is lupus autoantigen Ku80 and mediates lymphoid cell adhesion in vitro. , 2001, American journal of physiology. Cell physiology.
[71] G. Semenza,et al. Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. , 2001, Cancer research.
[72] Till Acker,et al. Up-regulation of hypoxia-inducible factors HIF-1α and HIF-2α under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function , 2000, Oncogene.
[73] M. Schindl,et al. Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. , 2000, Cancer research.
[74] J. M. Arbeit,et al. Hypoxia-inducible Factor-1α Is a Positive Factor in Solid Tumor Growth , 2000 .
[75] D. Faller,et al. Hypoxia affects tumor cell invasiveness in vitro: the role of hypoxia-activated ligand HAL1/13 (Ku86 autoantigen). , 2000, Cancer letters.
[76] G. Semenza,et al. Expression of hypoxia‐inducible factor 1α in brain tumors , 2000 .
[77] A. Koong,et al. Loss of PTEN facilitates HIF-1-mediated gene expression. , 2000, Genes & development.
[78] G. Semenza,et al. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. , 2000, Genes & development.
[79] G. Semenza,et al. Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2. , 1999, Cancer research.
[80] C. Wykoff,et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis , 1999, Nature.
[81] M. Gassmann,et al. Up-regulation of hypoxia-inducible factor-1alpha is not sufficient for hypoxic/anoxic p53 induction. , 1998, Cancer research.
[82] N. Osheroff,et al. Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme. , 1998, Biochimica et biophysica acta.
[83] Jessica Lo,et al. HIF‐1α is required for solid tumor formation and embryonic vascularization , 1998 .
[84] J. Brown,et al. Exploiting tumour hypoxia and overcoming mutant p53 with tirapazamine. , 1998, British Journal of Cancer.
[85] G. Semenza,et al. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. , 1997, Cancer research.
[86] L. H. Gray,et al. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. , 1953, The British journal of radiology.
[87] H. Shim. Hypoxia-Inducible Factor-1 , 2015 .